Literature DB >> 838859

Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

P E Lipsky, M Ziff.   

Abstract

Gold sodium thiomalate (GST) inhibited in vitro antigen- and mitogen-triggered human lymphocyte DNA synthesis. Inhibition of responsiveness was observed with concentrations of GST equivalent to gold levels found in serum or tissues of patients receiving chrysotherapy, Inhibition was dependent upon the gold ion itself since GST and gold chloride were both inhibitory whereas thiomalic acid was not. Inhibition could not be explained by nonspecific killing of cells or by an alteration in the kinetics of the responses. GST inhibited mitogen-induced proliferation most effectively when present from the initiation of culture and could not inhibit the responsiveness of cells which previously had been activated by concanvalin A. These findings indicated that GST blocked a critical early step in lymphocyte activation. The degree of GST-induced inhibition of proliferation was increased in cultures of cells partially depleted of monocytes. Moreover, inhibition was reversed by supplementation of these cultures with purified monocytes. These observations suggested that GST blocked thymus-derived (T)-lymphocyte activation by interfering with a requisite function of the monocyte population in initiating such responses. Prolonged incubation of peripheral blood mononuclear cells with GST resulted in diminished mitogen responsiveness upon subsequent culture in the absence of gold. The addition of fresh monocytes restored responsiveness to these populations. Furthermore, preincubation of purified monocytes with GST rendered them deficient in their ability to support mitogen-induced T-lymphocyte proliferation on subsequent culture. These observations indicate that the major effect of GST results from interference with the functional capability of the monocyte population.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 838859      PMCID: PMC333382          DOI: 10.1172/JCI108660

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Studies with radioactive gold.

Authors:  J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

Review 2.  Participation of mononuclear phagocytes in chronic inflammatory diseases.

Authors:  R C Page; P Davies; A C Allison
Journal:  J Reticuloendothel Soc       Date:  1974-05

3.  Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.

Authors:  J D Jessop; R G Johns
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

4.  Serum gold. II. Levels in rheumatoid arthritis.

Authors:  H M Rubinstein; A A Dietz
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

5.  Effect of sodium aurothiomalate "mycrosin" on DNA synthesis in phytohaemagglutin-stimulated cultures of sheep lymphocytes.

Authors:  R N Cahill
Journal:  Experientia       Date:  1971-08

6.  The effect of gold salt on lysosomal enzymes of the peritoneal macrophage.

Authors:  R H Persellin; M Ziff
Journal:  Arthritis Rheum       Date:  1966-02

Review 7.  In vitro approaches to the mechanism of cell-mediated immune reactions.

Authors:  B R Bloom
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

8.  In vitro synthesis of immunoglobulin by rheumatoid synovial membrane.

Authors:  J D Smiley; C Sachs; M Ziff
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

9.  Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes.

Authors:  D H Katz; E R Unanue
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  40 in total

1.  Unique properties of auranofin as a potential anti-rheumatic drug.

Authors:  M L Barrett; G P Lewis
Journal:  Agents Actions       Date:  1986-10

2.  A survey of the effect of metals on the immune response.

Authors:  L Treagan
Journal:  Biol Trace Elem Res       Date:  1979-06       Impact factor: 3.738

3.  Gold-specific T cells in rheumatoid arthritis patients treated with gold.

Authors:  P Romagnoli; G A Spinas; F Sinigaglia
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 4.  Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors:  M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

5.  Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos.

Authors:  M L Handel; C K Watts; A deFazio; R O Day; R L Sutherland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Cellular immunity to possible synovial antigens in rheumatoid arthritis.

Authors:  A D Robinson; K D Muirden
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

7.  The stimulation of IL-2 production by anti-rheumatic drugs.

Authors:  J A Oben; G R Wallace; B M Chain; J C Foreman
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

8.  Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.

Authors:  R J Coughlan; M B Richter; G S Panayi
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

9.  Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

Authors:  K Hashimoto; C E Whitehurst; T Matsubara; K Hirohata; P E Lipsky
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

10.  The effect of clotrimazole on human lymphocyte responsiveness to plant mitogens.

Authors:  P J Gow; V Corrigall; G S Panayi
Journal:  Agents Actions       Date:  1979-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.